Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intramuscular naloxone for opioid poisoning
ACTRN12621000062820Phase 4Completed
- Sponsor
- Princess Alexandra Hospital Clinical Toxicology Unit
- Start
- Oct 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in opioid intoxication comparing Intramuscular naloxone with Intramuscular saline placebo (2 arms). Primary endpoint: Recurrence of opioid toxicity. Started Oct 2021; status: completed.
02
Drugs
naloxone
03
Conditions
opioid intoxication
Beyond the preview
Go deeper on ACTRN12621000062820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12621000062820.